Finance Watch: Venture Capital Drives Record-Breaking Year For Cell And Gene Therapies

$8.2bn In VC Deals Through Q3 Is Up 45% Year-Over-Year

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.